INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

PRAXPraxis Precision Medicines, Inc.

CIK 0001689548

EDGAR filingsOpen in network
Disclosed transactions27
Buys / sells2 / 12
Max Insider Score28
Connections10with evidence

PRAX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
Gilbert Ray Cisneros, Jr.DSelf
PRAXPraxis Precision Medicines, Inc.
Purchase
BUY$1,001 – $15KSep 29, 2026Oct 12, 2026
traded Sep 29, 2026
+13dHOUSE PTR

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-09-04 · Sep 4, 2026
  • ← Lobbied forevidence
    BALLARD PARTNERSLDA RR 2026 third quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    THE KPM GROUP DC LLCLDA Q2 2026 second quarter · Pharmacy · Aug 26, 2026
28
Gilbert Ray Cisneros, Jr.DSelf
PRAXPraxis Precision Medicines, Inc.
Purchase
BUY
$1,001 – $15K
Jul 30, 2026
Sep 4, 2026
traded Jul 30, 2026
+36d
HOUSE PTR

Evidence

13
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Option exercise · 10b5-1 plan
M$447K
3,034 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

5
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$3,014
10 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

5
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$36K
120 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

8
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$98K
320 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

12
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$210K
683 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$382K
1,240 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$309K
999 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$544K
1,750 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$890K
2,854 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

15
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$314K
1,004 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

12
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$158K
504 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$403K
1,279 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

19
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Open-market sale · 10b5-1 plan
SELL$264K
837 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

0
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Option exercise · 10b5-1 plan
M—
8,566 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

0
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Option exercise · 10b5-1 plan
M—
3,034 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

17
DJ
DeSimone JillDirector
PRAXPraxis Precision Medicines, Inc.
Option exercise · 10b5-1 plan
M$379K
8,566 sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

12
SM
Sniecinski MeganChief Operating Officer
PRAXPraxis Precision Medicines, Inc.
Tax withholding
F$244K
885 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

12
ML
Mastrocola LaurenPrincipal Accounting Officer
PRAXPraxis Precision Medicines, Inc.
Tax withholding
F$95K
344 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

12
NA
Nemiroff AlexGeneral Counsel and Secretary
PRAXPraxis Precision Medicines, Inc.
Tax withholding
F$212K
768 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

15
KE
Kelly Timothy EdwinChief Financial Officer
PRAXPraxis Precision Medicines, Inc.
Tax withholding
F$260K
943 sh
Jan 12, 2026Jan 13, 2026
traded Jan 12, 2026
+1dSEC FORM 4

Evidence

12
SM
Souza MarcioDirector, Chief Executive Officer
PRAXPraxis Precision Medicines, Inc.
Tax withholding
F$119K
405 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

9
KE
Kelly Timothy EdwinChief Financial Officer
PRAXPraxis Precision Medicines, Inc.
Tax withholding
F$41K
139 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

9
NA
Nemiroff AlexGeneral Counsel and Secretary
PRAXPraxis Precision Medicines, Inc.
Tax withholding
F$26K
89 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

9
ML
Mastrocola LaurenPrincipal Accounting Officer
PRAXPraxis Precision Medicines, Inc.
Tax withholding
F$10K
35 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

16
SM
Souza MarcioDirector, Chief Executive Officer
PRAXPraxis Precision Medicines, Inc.
Gift
G—
400 sh
Dec 30, 2025Dec 31, 2025
traded Dec 30, 2025
+1dSEC FORM 4

Evidence

  • ← Insider ofevidence
    DeSimone JillDirector · Jun 26, 2026
  • ← Insider ofevidence
    Sniecinski MeganChief Operating Officer · Jan 13, 2026
  • ← Insider ofevidence
    Nemiroff AlexGeneral Counsel and Secretary · Jan 9, 2026
  • ← Insider ofevidence
    Mastrocola LaurenPrincipal Accounting Officer · Jan 9, 2026
  • ← Insider ofevidence
    Kelly Timothy EdwinChief Financial Officer · Jan 9, 2026
  • ← Insider ofevidence
    Souza MarcioDirector, Chief Executive Officer · Dec 31, 2025

    • Lobbying

    $120K reported · de-duplicated
    2026 Q3 $0 via firms2026 Q2 $80K via firms2026 Q1 $40K via firms
    • THE KPM GROUP DC LLC$40K2026 Q2 · posted Aug 26, 2026 · Pharmacy
    • BALLARD PARTNERS—2026 Q3 · posted Aug 26, 2026 · Health issues
    • THE KPM GROUP DC LLC$40K2026 Q1 · posted Aug 26, 2026 · Pharmacy
    • THE KPM GROUP DC LLC$40K2026 Q2 · posted Aug 26, 2026 · Pharmacy

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.